Clinical Trials

Breast Neoplasms

NCT05325632 2026-03-02

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

53 enrolled

Breast Neoplasms

NCT05505643 2026-02-27

COOL-IT

120 enrolled

Breast Neoplasms

NCT07053085 2026-02-27

A Study of Surgery and Radiotherapy in People With Breast Cancer

162 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT02927912 2026-02-17

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

108 enrolled

Breast Neoplasms

NCT06291064 2026-02-17

TARMAC

85 enrolled

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02624973 2026-02-12

PETREMAC

Phase NA Not yet recruiting

Breast Neoplasms

NCT07345026 2026-01-15

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

116 enrolled

Breast Neoplasms

NCT04854005 2026-01-12

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Active not recruiting

78 enrolled

Breast Neoplasms

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

120 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06092892 2025-12-10

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

45 enrolled

Breast Neoplasms, Lymphedema

NCT03546686 2025-10-27

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

80 enrolled

Breast Neoplasms

NCT07140965 2025-10-22

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

Active not recruiting

175 enrolled

Breast Neoplasms

NCT07211451 2025-10-08

Axillary Nodal Burden in HER2+ and TNBC

1,571 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07169903 2025-09-12

STAR012

587 enrolled

Adenocarcinoma of Lung

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

30 enrolled

Carcinoma, Lobular

NCT01805076 2025-09-05

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Phase 3 Completed

317 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06839001 2025-06-26

CRYSTAL - SIX

Phase 3 Recruiting

750 enrolled

Breast Neoplasms

NCT06209099 2025-06-12

Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

96 enrolled

Rectal Neoplasms

NCT03612648 2025-03-24

Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma

77 enrolled

Breast Neoplasms

NCT00185744 2025-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

121 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Carcinoma, Ductal

NCT05545150 2025-02-07

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

113 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT02772731 2025-01-31

SHAVE2

Phase NA Completed

400 enrolled

Breast Neoplasms

NCT06496659 2024-11-14

SAINT

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06249672 2024-11-13

PRESERVE

Phase NA Not yet recruiting

Rectal Neoplasms

NCT06646770 2024-10-17

SELTIC

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06634966 2024-10-10

Segmentectomy for Solid-dominant Lung Cancer

Phase 3 Recruiting

277 enrolled

Adenocarcinoma of Lung

NCT06603805 2024-09-19

Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study

974 enrolled

Breast Neoplasms

NCT04937283 2024-06-17

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

690 enrolled

Adenocarcinoma of Lung

NCT05717803 2024-06-03

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Phase 3 Recruiting

307 enrolled

Adenocarcinoma of Lung

NCT06429644 2024-05-28

Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

4,010 enrolled

BRCA1/2 Mutation

NCT01618357 2024-05-22

Pre-Operative Radiation and Veliparib for Breast Cancer

Phase 1 Completed

19 enrolled

Breast Neoplasms

NCT06425874 2024-05-22

The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery

1,000 enrolled

Breast Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

Phase 1/2 Unknown

20 enrolled

Pancreatic Neoplasms, Rectal Neoplasms

NCT05257577 2024-04-24

FIBRATIO

Active not recruiting

220 enrolled

Phase NA Not yet recruiting

Margins of Excision, Breast Neoplasms, Patient Satisfaction

NCT06131632 2024-01-23

ConSIBreC

300 enrolled

Inflammatory Breast Neoplasms

NCT04805736 2024-01-05

Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer

Phase 2 Completed

60 enrolled

Breast Neoplasms

NCT04902937 2023-11-28

CETC

Neoplastic Cells, Circulating

NCT05876390 2023-11-09

IRACPoP

Unknown

1,500 enrolled

Breast Neoplasms, Pain, Postoperative

NCT06103032 2023-10-26

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

1,020 enrolled

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT01980823 2023-08-30

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

23 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT05969847 2023-08-01

TRACE-LE

72 enrolled

Rectal Neoplasms

NCT05838053 2023-07-27

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

446 enrolled

Adenocarcinoma of Lung

NCT05707767 2023-07-19

A Prospective Study of Surgical Treatment Strategies for Chordoma

Phase NA Unknown

100 enrolled

Sarcoma

Chordoma

NCT05400954 2023-04-28

AREOLA-B

Unknown

15,000 enrolled

Autoimmune Diseases, Breast Neoplasms

NCT05772923 2023-03-17

OPAXX

168 enrolled

Rectal Neoplasms

NCT05724758 2023-02-13

Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery

Unknown

100 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

358 enrolled